Ask Our Doctors and Nurses!

ALIMTA Side Effect?
Don't put Your Health at Risk - Take Action Now! Type your question here

 letters left

ALIMTA Safety Reports

Total ALIMTA reports: 342.
ALIMTA FDA safety alerts: No.
Reported deaths: 74    Reported hospitalizations: 176.
Take ALIMTA Side Effects Survey or Share Your ALIMTA Story. Read More Here.

Showing 1-75 of 342 Next >

Physician from reported ALIMTA problem on Mar 28, 2007. Male patient, 73 years of age, was diagnosed with lung squamous cell carcinoma stage ii and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: urticaria. ALIMTA dosage: 500 MG, OTHER. Patient recovered.

ALIMTA problem was reported by a Physician from UNITED STATES on Apr 02, 2007. Female patient, 69 years of age, weighting 143.3 lb, was diagnosed with non-small cell lung cancer, vitamin supplementation and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: large intestine perforation, septic shock. ALIMTA dosage: 500 MG/M2, UNK. During the same period patient was treated with CARBOPLATIN, AVASTIN, VITAMIN B, FOLIC ACID, WELLBUTRIN, NORVASC, LIPITOR, OXYCODONE. Patient died on 02/13/2007.

Physician from reported ALIMTA problem on Mar 28, 2007. Male patient, 64 years of age, was diagnosed with lung adenocarcinoma metastatic and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: urticaria. ALIMTA dosage: 500 MG, OTHER. Patient recovered.

ALIMTA problem was reported by a Physician from ITALY on Mar 28, 2007. Male patient, 52 years of age, was diagnosed with pleural mesothelioma malignant and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: erythema, oedema peripheral. ALIMTA dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Physician from reported ALIMTA problem on Mar 28, 2007. Male patient, 70 years of age, was diagnosed with lung adenocarcinoma metastatic and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: urticaria. ALIMTA dosage: 500 MG, OTHER. Patient recovered.

ALIMTA problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 06, 2007. Female patient was diagnosed with chondrosarcoma metastatic and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: condition aggravated, cough, dyspnoea, headache, hyperglycaemia, hyperkalaemia, hypocalcaemia, hypomagnesaemia, hypotension. ALIMTA dosage: 500 MG/M2 D1 Q 21 DAY IV. During the same period patient was treated with TARCEVA. Patient recovered.

Physician from UNITED STATES reported ALIMTA problem on Apr 05, 2007. Male patient, 70 years of age, weighting 211.0 lb, was diagnosed with non-small cell lung cancer metastatic, vitamin supplementation and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: azotaemia, diarrhoea, neutropenia, thrombocytopenia. ALIMTA dosage: 1000 MG, UNK. During the same period patient was treated with VITAMIN B, FOLIC ACID. Patient was hospitalized. Patient recovered.

ALIMTA problem was reported by a Physician from UNITED STATES on Apr 05, 2007. Female patient, 82 years of age, was diagnosed with lung neoplasm malignant, vitamin supplementation and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. ALIMTA dosage: unknown. During the same period patient was treated with VITAMIN B, FOLIC ACID. Patient recovered.

Physician from UNITED STATES reported ALIMTA problem on Apr 03, 2007. Male patient was diagnosed with non-small cell lung cancer stage iv and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: adverse event, neutrophil count decreased, pyrexia. ALIMTA dosage: 500 MG, UNK. Patient was hospitalized. Patient recovered.

ALIMTA problem was reported by a Physician from UNITED STATES on Apr 06, 2007. Female patient was diagnosed with non-small cell lung cancer, prophylaxis and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction. ALIMTA dosage: unknown. During the same period patient was treated with DECADRON. Patient recovered.

Physician from reported ALIMTA problem on Apr 13, 2007. Male patient, 76 years of age, was diagnosed with lung neoplasm malignant and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: myocardial infarction, pancytopenia, pseudomonas infection. ALIMTA dosage: 500 MG/M2, OTHER. During the same period patient was treated with CORTICOSTEROID NOS, FOLIC ACID, VITAMIN B. Patient was hospitalized. Patient died on 04/01/2007.

ALIMTA problem was reported by a Physician from FRANCE on Apr 13, 2007. Male patient, 67 years of age, weighting 218.3 lb, was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: anaemia, epistaxis, melanodermia, mucosal inflammation, neutropenia, prothrombin time ratio decreased, renal failure acute, thrombocytopenia. ALIMTA dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported ALIMTA problem on Apr 10, 2007. Male patient, 63 years of age, weighting 185.0 lb, was diagnosed with lung cancer metastatic, prophylaxis, nausea, vitamin supplementation and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, convulsion, dizziness, dyspepsia, erythema, feeling hot, flushing, nausea, pruritus. ALIMTA dosage: 1000 MG, OTHER. During the same period patient was treated with DECADRON, PALONOSETRON HYDROCHLORIDE, VITAMIN B, FOLIC ACID, DEXAMETHASONE, ZANTAC. Patient recovered.

ALIMTA problem was reported by a Physician from FRANCE on Apr 16, 2007. Male patient, 74 years of age, weighting 152.1 lb, was diagnosed with lung adenocarcinoma, hypertension, lipid metabolism disorder, pain and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: oral fungal infection, rash maculo-papular. ALIMTA dosage: 760 MG, OTHER. During the same period patient was treated with KARDEGIC, OMEPRAZOLE, KREDEX, CRESTOR, LARGACTIL, DOLIPRANE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ALIMTA problem on Apr 13, 2007. Female patient, 84 years of age, was diagnosed with mesothelioma and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: dyspnoea, pulmonary embolism, pulmonary oedema. ALIMTA dosage: unknown. During the same period patient was treated with VITAMINS NOS. Patient was hospitalized. Patient recovered.

ALIMTA problem was reported by a Physician from GERMANY on Apr 13, 2007. Male patient, 57 years of age, was diagnosed with non-small cell lung cancer and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, gastric ulcer haemorrhage, melaena, oesophagitis haemorrhagic. ALIMTA dosage: 977 MG, UNK. During the same period patient was treated with NEXIUM, TAVEGIL, ZOLOFT, VITAMIN B, KALINOR, FOLIC ACID, DEXAMETHASONE. Patient was hospitalized. Patient died on 01/10/2007.

Physician from UNITED STATES reported ALIMTA problem on Apr 17, 2007. Female patient was diagnosed with vitamin supplementation and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: no adverse effect. ALIMTA dosage: unknown. During the same period patient was treated with CISPLATIN, VITAMIN B12 NOS, FOLIC ACID. Patient recovered.

ALIMTA problem was reported by a Physician from UNITED STATES on Apr 17, 2007. Female patient, 64 years of age, was diagnosed with non-small cell lung cancer stage iiib, vitamin supplementation and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: haemolytic anaemia. ALIMTA dosage: unknown. During the same period patient was treated with CENTRUM SILVER, FERROUS SULPHATE, ZOCOR, HYDROCHLOROTHIAZIDE, METFORMIN, ACTOS, CALTRATE, FOLIC ACID. Patient recovered.

Physician from UNITED STATES reported ALIMTA problem on Apr 19, 2007. Male patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: neutropenia. ALIMTA dosage: 500 MG/M2, UNK. During the same period patient was treated with VITAMIN B, FOLIC ACID, ZOFRAN, NEULASTA. Patient died on 04/19/2007.

ALIMTA problem was reported by a Physician from UNITED STATES on Apr 19, 2007. Male patient, 58 years of age, weighting 176.4 lb, was diagnosed with mesothelioma malignant and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, febrile neutropenia, thrombocytopenia. ALIMTA dosage: 1000 MG, UNK. Patient was hospitalized. Patient recovered.

Physician from SOUTH AFRICA reported ALIMTA problem on Apr 23, 2007. Female patient, 63 years of age, was diagnosed with non-small cell lung cancer, prophylaxis, pain, asthma and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression. ALIMTA dosage: unknown. During the same period patient was treated with FOLIC ACID, VITAMIN B, DEXAMETHASONE, DURAGESIC, VENTOLIN. Patient died on 01/21/2007.

ALIMTA problem was reported by a Physician from FRANCE on Apr 19, 2007. Male patient, 68 years of age, was diagnosed with non-small cell lung cancer and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: neutropenia, pyrexia, thrombocytopenia. ALIMTA dosage: 500 MG/M2, OTHER. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported ALIMTA problem on Jan 03, 2007. Male patient, 51 years of age, was diagnosed with non-small cell lung cancer and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: conjunctivitis, injection site irritation, malignant neoplasm progression. ALIMTA dosage: unknown. During the same period patient was treated with GEMZAR. Patient recovered.

ALIMTA problem was reported by a Physician from UNITED STATES on Oct 26, 2006. Male patient, 79 years of age, was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: anaemia macrocytic. ALIMTA dosage: unknown. Patient recovered.

Physician from UNITED STATES reported ALIMTA problem on Dec 15, 2006. Male patient, 60 years of age, was diagnosed with non-small cell lung cancer and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis. ALIMTA dosage: 500 MG/M2, INTRAVENOUS. Patient recovered.

ALIMTA problem was reported by a Physician from UNITED STATES on Jan 03, 2007. Male patient, 51 years of age, was diagnosed with non-small cell lung cancer and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: conjunctivitis, injection site irritation, malignant neoplasm progression. ALIMTA dosage: unknown. During the same period patient was treated with GEMZAR. Patient recovered.

Physician from UNITED STATES reported ALIMTA problem on Jan 19, 2007. Male patient, 73 years of age, was diagnosed with non-small cell lung cancer stage iv and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: anaemia, malignant neoplasm progression, thrombocytopenia. ALIMTA dosage: unknown. Patient recovered.

ALIMTA problem was reported by a Physician from UNITED STATES on Jan 22, 2007. Male patient, 76 years of age, was diagnosed with non-small cell lung cancer and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: fatigue. ALIMTA dosage: 500 MG/M2. During the same period patient was treated with FOLIC ACID, DEXAMETHASONE, VITAMIN B12. Patient recovered.

Physician from UNITED STATES reported ALIMTA problem on Jan 24, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: bone marrow failure. ALIMTA dosage: 500 MG/M2. Patient recovered.

ALIMTA problem was reported by a Physician from UNITED STATES on Jan 25, 2007. Male patient, 47 years of age, was diagnosed with mesothelioma and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: disease progression. ALIMTA dosage: unknown. During the same period patient was treated with CISPLATIN, FOLIC ACID, VITAMIN B. Patient recovered.

Health Professional from UNITED STATES reported ALIMTA problem on Dec 07, 2006. Male patient, 40 years of age, was diagnosed with non-small cell lung cancer and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: dysuria. ALIMTA dosage: unknown. During the same period patient was treated with AVASTIN, FOLIC ACID, VITAMIN B12. Patient recovered.

ALIMTA problem was reported by a Physician from UNITED STATES on Dec 11, 2006. Male patient was diagnosed with mesothelioma and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, dizziness, hypersensitivity, paraesthesia. ALIMTA dosage: unknown. During the same period patient was treated with CARBOPLATIN, CORTICOSTEROID NOS, FOLIC ACID, VITAMIN B12. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ALIMTA problem on Dec 06, 2006. Male patient, 51 years of age, was diagnosed with mesothelioma and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: hallucination, auditory, sleep disorder. ALIMTA dosage: unknown. During the same period patient was treated with FENTANYL, MORPHINE SULPHATE, VITAMIN B12, FOLIC ACID, DEXAMETHASONE, XANAX. Patient recovered.

ALIMTA problem was reported by a Health Professional from UNITED STATES on Dec 08, 2006. Male patient, 75 years of age, was diagnosed with mesothelioma and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: anorexia, dysgeusia, parosmia. ALIMTA dosage: unknown. During the same period patient was treated with CISPLATIN, FOLIC ACID, VITAMIN B12ECTION, EMEND, MAGNESIUM, DECADRON, PALONOSETRON, MANNITOL. Patient recovered.

Health Professional from UNITED STATES reported ALIMTA problem on Dec 11, 2006. Male patient was diagnosed with neoplasm malignant and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: lacrimation increased. ALIMTA dosage: unknown. During the same period patient was treated with FOLIC ACID, VITAMIN B12, ZOMETA, ARANESP. Patient recovered.

ALIMTA problem was reported by a Physician from UNITED STATES on Dec 15, 2006. Male patient was diagnosed with non-small cell lung cancer and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: dizziness, flushing. ALIMTA dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ALIMTA problem on Dec 19, 2006. Male patient was diagnosed with lung neoplasm malignant and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: anorexia, dysgeusia, nausea, vomiting, weight decreased. ALIMTA dosage: unknown. During the same period patient was treated with VITAMIN B12, FOLIC ACID, DEXAMETHASONE, ANTIHYPERTENSIVES. Patient recovered.

ALIMTA problem was reported by a Physician from UNITED STATES on Jan 31, 2007. Male patient, 75 years of age, was diagnosed with non-small cell lung cancer and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: recall phenomenon. ALIMTA dosage: 500 MG/M2. During the same period patient was treated with VITAMIN B12, FOLIC ACID, DECADRON, TAXOTERE. Patient recovered.

Physician from GERMANY reported ALIMTA problem on Apr 25, 2007. Male patient was diagnosed with non-small cell lung cancer stage iv and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, sepsis, viral infection. ALIMTA dosage: 500 MG/M2, UNK. Patient died on 04/19/2007.

ALIMTA problem was reported by a Consumer or non-health professional from UNITED STATES on May 04, 2007. Male patient, weighting 175.9 lb, was treated with ALIMTA. ALIMTA dosage: 975 MG. Patient was hospitalized. Patient died on 04/03/2007.

Physician from UNITED STATES reported ALIMTA problem on May 01, 2007. Male patient was diagnosed with non-small cell lung cancer and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: asthenia, brain neoplasm, fall, fatigue. ALIMTA dosage: 500 MG, UNK. During the same period patient was treated with VITAMIN B, FOLIC ACID. Patient recovered.

ALIMTA problem was reported by a Physician from UNITED STATES on May 02, 2007. Female patient, 69 years of age, weighting 143.3 lb, was diagnosed with non-small cell lung cancer, vitamin supplementation and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: large intestine perforation, septic shock. ALIMTA dosage: 500 MG/M2, UNK. During the same period patient was treated with CARBOPLATIN, AVASTIN, VITAMIN B, FOLIC ACID, WELLBUTRIN, NORVASC, LIPITOR, OXYCODONE. Patient died on 02/13/2007.

Physician from FRANCE reported ALIMTA problem on May 03, 2007. Female patient, 66 years of age, was diagnosed with non-small cell lung cancer, vitamin supplementation, prophylaxis and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, renal failure, septic shock. ALIMTA dosage: unknown. During the same period patient was treated with FOLIC ACID, VITAMIN B, CORTICOSTEROID NOS. Patient was hospitalized. Patient died on 04/30/2007.

ALIMTA problem was reported by a Consumer or non-health professional from UNITED STATES on May 03, 2007. Female patient, 77 years of age, weighting 170.0 lb, was diagnosed with non-small cell lung cancer and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: dehydration, nausea, pneumonitis. ALIMTA dosage: 664 MG Q 2 WEEKS IV. During the same period patient was treated with GEMCITABINE, METAMUCIL, NORVASC, XANAX, PRILOSEC, COMPAZINE, CALTRATE, VITAMIN D. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported ALIMTA problem on May 08, 2007. Male patient, weighting 146.0 lb, was diagnosed with neoplasm malignant and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: mouth haemorrhage. ALIMTA dosage: 895 MG/IV EVERY 3 WEEKS. During the same period patient was treated with AVASTIN. Patient was hospitalized. Patient recovered.

ALIMTA problem was reported by a Health Professional from UNITED STATES on May 08, 2007. Male patient, weighting 146.0 lb, was diagnosed with neoplasm malignant and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: mouth haemorrhage. ALIMTA dosage: 895 MG IV /EVERY 3 WEEKS. During the same period patient was treated with AVASTIN. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported ALIMTA problem on May 03, 2007. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer, vitamin supplementation and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: haemolytic anaemia. ALIMTA dosage: 500 MG, UNK. During the same period patient was treated with FOLIC ACID, VITAMIN B, DEXAMETHASONE. Patient recovered.

ALIMTA problem was reported by a Physician from UNITED STATES on May 07, 2007. Male patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. ALIMTA dosage: 500 MG/M2, UNK. During the same period patient was treated with VITAMIN B, FOLIC ACID, ZOFRAN, NEULASTA. Patient died on 04/19/2007.

Physician from FRANCE reported ALIMTA problem on May 10, 2007. Female patient, 53 years of age, weighting 174.2 lb, was diagnosed with non-small cell lung cancer, vitamin supplementation and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease, sinusitis, skin hyperpigmentation. ALIMTA dosage: 930 MG, OTHER. During the same period patient was treated with SOLUPRED, FOLIC ACID, VITAMIN B, ZOFRAN. Patient recovered.

ALIMTA problem was reported by a Health Professional from UNITED STATES on May 10, 2007. Male patient, 56 years of age, weighting 186.0 lb, was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: gingivitis, osteonecrosis, toothache. ALIMTA dosage: unknown. During the same period patient was treated with ZOMETA. Patient recovered.

Physician from FRANCE reported ALIMTA problem on May 14, 2007. Female patient, 67 years of age, weighting 149.9 lb, was diagnosed with lung adenocarcinoma metastatic, vitamin supplementation and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, hemiplegia, malignant neoplasm progression, thrombocytopenia. ALIMTA dosage: 800 MG, OTHER. During the same period patient was treated with FOLIC ACID, VITAMIN B, DEXAMETHASONE. Patient was hospitalized and became disabled. Patient died.

ALIMTA problem was reported by a Physician from GERMANY on May 16, 2007. Male patient, 59 years of age, was diagnosed with pleural mesothelioma and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: congestive cardiomyopathy. ALIMTA dosage: 400 MG/M2, OTHER. During the same period patient was treated with TAXOTERE. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported ALIMTA problem on May 23, 2007. Male patient, 59 years of age, was diagnosed with pleural mesothelioma and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: anaemia, congestive cardiomyopathy. ALIMTA dosage: 400 MG/M2, OTHER. During the same period patient was treated with CARBOPLATIN, FOLIC ACID, VITAMIN B, DEXAMETHASONE, MARCUMAR. Patient was hospitalized. Patient recovered.

ALIMTA problem was reported by a Physician from FRANCE on May 23, 2007. Female patient, 54 years of age, was diagnosed with lung adenocarcinoma and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: gamma-glutamyltransferase increased, mixed hepatocellular-cholestatic injury, rash pruritic. ALIMTA dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported ALIMTA problem on May 24, 2007. Male patient, 57 years of age, was diagnosed with non-small cell lung cancer and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: helicobacter pylori identification test positive, malignant neoplasm progression. ALIMTA dosage: 500 MG/M2, UNK. Patient died.

ALIMTA problem was reported by a Physician from FRANCE on May 30, 2007. Female patient, 64 years of age, weighting 119.0 lb, was diagnosed with lung neoplasm malignant and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: balance disorder, drop attacks, fall. ALIMTA dosage: 500 MG, OTHER. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ALIMTA problem on May 25, 2007. Female patient, 84 years of age, was diagnosed with mesothelioma and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: dyspnoea, pulmonary embolism, pulmonary oedema. ALIMTA dosage: unknown. During the same period patient was treated with VITAMINS NOS. Patient was hospitalized. Patient died on 05/25/2007.

ALIMTA problem was reported by a Health Professional from UNITED STATES on June 04, 2007. Male patient, 55 years of age, weighting 298.0 lb, was diagnosed with tonsil cancer and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: deafness. ALIMTA dosage: 500MG/M2 DAY 1 PER CYCLE X 7 CYCLES IV OVER 10 MINUTES C4D1 DOSE. During the same period patient was treated with OXALIPLATIN. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported ALIMTA problem on May 29, 2007. Female patient, 57 years of age, weighting 191.8 lb, was diagnosed with lung adenocarcinoma metastatic, vitamin supplementation, prophylaxis and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: asthenia, candidiasis, hyperthermia, nausea, pancytopenia, renal failure acute, vomiting. ALIMTA dosage: 500 MG/M2, OTHER. During the same period patient was treated with TARCEVA, FOLIC ACID, VITAMIN B, GRANOCYTE, NEORECORMON, GLUCOPHAGE, IMODIUM, LYTOS. Patient was hospitalized. Patient recovered.

ALIMTA problem was reported by a Physician from UNITED STATES on June 04, 2007. Male patient, 76 years of age, was diagnosed with non-small cell lung cancer and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: leukoencephalopathy, neutropenia, thrombocytopenia. ALIMTA dosage: unknown. During the same period patient was treated with AVASTIN. Patient recovered.

Physician from FRANCE reported ALIMTA problem on June 04, 2007. Female patient, 68 years of age, was diagnosed with lung neoplasm malignant, vitamin supplementation, prophylaxis and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: vertigo positional. ALIMTA dosage: 500 MG/M2, OTHER. During the same period patient was treated with FOLIC ACID, VITAMIN B, CORTICOSTEROIDS. Patient recovered.

ALIMTA problem was reported by a Physician from FRANCE on June 06, 2007. Female patient, 54 years of age, was diagnosed with lung adenocarcinoma and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: gamma-glutamyltransferase increased, intracranial pressure increased, mixed hepatocellular-cholestatic injury, rash pruritic. ALIMTA dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported ALIMTA problem on June 07, 2007. Male patient, 57 years of age, was diagnosed with non-small cell lung cancer, vitamin supplementation and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: helicobacter pylori identification test positive, malignant neoplasm progression. ALIMTA dosage: 500 MG/M2, UNK. During the same period patient was treated with FOLIC ACID, VITAMIN B12 NOS. Patient died.

ALIMTA problem was reported by a Health Professional from UNITED STATES on June 08, 2007. Male patient, 55 years of age, weighting 298.0 lb, was diagnosed with tonsil cancer and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: deafness neurosensory, oral intake reduced. ALIMTA dosage: 500 MG/M2. During the same period patient was treated with OXALIPLATIN. Patient was hospitalized. Patient recovered.

Physician from ITALY reported ALIMTA problem on June 04, 2007. Male patient, 49 years of age, was diagnosed with mesothelioma malignant and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. ALIMTA dosage: 1000 MG, OTHER. During the same period patient was treated with FOLIC ACID, VITAMIN B, CORTICOSTEROIDS, CISPLATIN. Patient was hospitalized. Patient recovered.

ALIMTA problem was reported by a Health Professional from UNITED STATES on June 12, 2007. Male patient, 75 years of age, weighting 201.0 lb, was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: anaemia, upper gastrointestinal haemorrhage. ALIMTA dosage: 500MG/M2. During the same period patient was treated with ERBITUX. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported ALIMTA problem on June 13, 2007. Male patient, 63 years of age, weighting 121.3 lb, was diagnosed with non-small cell lung cancer, prophylaxis of nausea and vomiting and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: amnesia, c-reactive protein increased, decreased appetite, depressed level of consciousness, metastases to central nervous system. ALIMTA dosage: 500 MG/M2, UNK. During the same period patient was treated with DEXAMETHASONE, KEVATRIL. Patient was hospitalized. Patient recovered.

ALIMTA problem was reported by a Consumer or non-health professional from UNITED STATES on June 19, 2007. Male patient, weighting 220.0 lb, was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: fatigue, scab, tongue injury. ALIMTA dosage: 880 MG. During the same period patient was treated with CARBOPLATIN. Patient recovered.

Physician from ITALY reported ALIMTA problem on June 18, 2007. Female patient, 72 years of age, was diagnosed with pleural mesothelioma and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: pancytopenia. ALIMTA dosage: 700 MG, OTHER. During the same period patient was treated with CISPLATIN, FOLIC ACID, VITAMIN B, CORTICOSTEROIDS. Patient was hospitalized. Patient died on 06/13/2007.

ALIMTA problem was reported by a Health Professional from UNITED STATES on June 25, 2007. Male patient, 75 years of age, weighting 201.0 lb, was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: anaemia, duodenal ulcer haemorrhage, neutrophil count abnormal, thrombocytopenia. ALIMTA dosage: 500MG/M2. During the same period patient was treated with ERBITUX. Patient died on 06/22/2007.

Health Professional from UNITED STATES reported ALIMTA problem on June 25, 2007. Male patient, 48 years of age, weighting 134.0 lb, was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: renal failure acute. ALIMTA dosage: IV/500MG/M2 Q3 WKS. During the same period patient was treated with ERBITUX, RADIATION. Patient was hospitalized. Patient recovered.

ALIMTA problem was reported by a Physician from ITALY on June 18, 2007. Female patient, 72 years of age, was diagnosed with mesothelioma malignant and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: mucosal inflammation, tendon rupture, tendonitis. ALIMTA dosage: 500 MG/M2, OTHER. During the same period patient was treated with CARBOPLATIN, FOLIC ACID, VITAMIN B, CORTICOSTEROIDS. Patient recovered.

Physician from UNITED STATES reported ALIMTA problem on June 29, 2007. Male patient, weighting 269.0 lb, was diagnosed with lung neoplasm malignant and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased. ALIMTA dosage: 1000MG ONCE IV DRIP. Patient was hospitalized. Patient recovered.

ALIMTA problem was reported by a Physician from UNITED STATES on July 10, 2006. Female patient, 66 years of age, weighting 161.2 lb, was diagnosed with bladder cancer and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal tenderness, diarrhoea, fatigue, flatulence, gastrointestinal perforation, musculoskeletal pain, pyrexia. ALIMTA dosage: 540MG Q2WEEKS IV. During the same period patient was treated with TAXOTERE, COUMADIN, DEXAMETHASONE, SYNTHROID, ZANTAC, CLARITIN. Patient was hospitalized. Patient recovered.

Physician from TAIWAN, PROVINCE OF CHINA reported ALIMTA problem on June 15, 2006. Male patient, 82 years of age, weighting 134.5 lb, was diagnosed with lung neoplasm malignant and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: blood creatine decreased, blood potassium decreased, blood sodium decreased, blood urea increased, colitis, decreased appetite, dehydration, depressed level of consciousness, enterococcal bacteraemia. ALIMTA dosage: 850 MG/M2, INTRAVENOUS. During the same period patient was treated with FOLIC ACID, DEXAMETHASONE, CYANOCOBALAMIN. Patient was hospitalized. Patient recovered.

Showing 1-75 of 342 Next >